32 results
SC TO-T
EX-99
SNCE
Science 37 Holdings Inc
12 Feb 24
Third party tender offer statement
8:16am
, enabling recruitment of virtually any patient. Science 37 believes that centering the clinical trial around the patient with personalized support addresses …
current industry needs around patient recruitment, retention, representation, and engagement. To expand clinical trial access, Science 37 offers
SC14D9C
EX-99.6
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
.
The strategic merger aims to combine eMed’s extensive access to patients and patient engagement technology with Science 37’s existing patient recruitment
SC14D9C
EX-99.5
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
.
The strategic merger aims to combine eMed’s extensive access to patients and patient engagement technology with Science 37’s existing patient recruitment
8-K
EX-2.1
SNCE
Science 37 Holdings Inc
29 Jan 24
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
7:35am
reduction efforts by the Company, undesired clinical results, insufficient patient enrollment or investigator recruitment and patient safety concerns
SC TO-I
EX-99
zvi85z
3 Apr 23
Issuer tender offer statement
8:00am
S-8
EX-99.1
ez2tw8uto4d1iz i9o
10 Nov 22
Registration of securities for employees
4:32pm
8-K
EX-99.1
cv8f34noed836m9
11 Aug 22
Science 37 Reports Second Quarter 2022 Financial Results
6:01am
424B3
2q6umr2nnfcuk8 3j6
4 May 22
Prospectus supplement
12:43pm
424B3
q2dwnoy
27 Apr 22
Prospectus supplement
4:19pm
POS AM
wmdsto9qe 3z
8 Apr 22
Prospectus update (post-effective amendment)
4:41pm
424B3
f8ys a1cbw
22 Mar 22
Prospectus supplement
7:28am
424B3
pndmxg
10 Feb 22
Prospectus supplement
12:00am
S-8
EX-99.1
2tj2l9uwa frs4kd5
10 Feb 22
Registration of securities for employees
12:00am